close

Enter

Log in using OpenID

Acute Myeloid Leukaemia Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

embed
The global acute myeloid leukaemia market is poised to value over US$ 1.5 billion by the end of 2026 and registering a CAGR of over 12% during the forecast period, 2019 to 2026
Title:
Acute Myeloid Leukaemia Market Global Trends,
Market Share, Industry Size, Growth, Opportunities, and
Market Forecast 2019 to 2026
The global acute myeloid leukaemia market is poised to value over US$ 1.5 billion by the end
of 2026 and registering a CAGR of over 12% during the forecast period, 2019 to 2026
Radiation exposure, carcinogenic environmental components, unhealthy lifestyle and genetic
mutations are mainly responsible for acute myeloid leukaemia (AML). The emergence of
alternative AML therapeutics like Tyrosine Kinase Inhibitors, monoclonal antibodies and
multidrug-resistant modulators provides significant benefits such as improved chances of early
detection of cancer cells, improved quality and safety, reduction in relapse percentage, long
term survival rates and so on.
Some of the major factors impelling the growth of the global acute myeloid leukaemia market
include:
• High mortality rate owing to AML
• Increasing relapse incidences
• The limited response of present medical solutions to treat AML
• Adverse effects of traditional treatments like tissue damage and loss of appetite in patients
• A rise in the cancer-prone ageing population
• Innovative drug development solutions using molecular biology
• Propelling investments in pharmaceutical R&D by market players
• Research incentives and rapid approvals by government bodies
• Availability of tests that can predict the compatibility of a particular patient with drug or
combination of drugs in achieving positive results
Global Acute Myeloid Leukaemia Market Competitive Scenario
The small and mid-sized pharmaceutical companies are exhibiting prominent presence with
technologically innovative therapeutic techniques providing viable results. The overall market
players pool is competitive with major players like Teva Pharmaceuticals, Novartis AG and
Pfizer. New drug pipelines, extensive clinical trials and collaborations to proliferate geographic
presence would remain major attention area to gain a competitive advantage in coming years.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=177&page=requestsample
Global Acute Myeloid Leukaemia Market Restraints
+ Lack of standardised treatments
+ Mounting preference towards stem cell replacement as an alternative solution
+ Heavily dominated market with the generics
+ High cost of therapeutic treatment processes coupled with safety apprehensions
Global Acute Myeloid Leukaemia Market by Drug Class
+ Tyrosine Kinase Inhibitors
+ Hedgehog Pathway Inhibitors
+ Topoisomerase 2 Inhibitors
+ Others
Tyrosine Kinase Inhibitors have undergone clinical evaluation for identification of recurring
mutations in all phases of drug development, clinical trials (both single agents plus combination
with chemotherapeutics) with promising anti-leukemic activity outcomes. The biomolecule
induces the mobilization of the hematopoietic progenitors and stem cells in vivo which potentially
aid the human biological system to kill cancer cells. Hence this drug class segment is estimated
to dominate the global AML market over the next couple of years.
Global Acute Myeloid Leukaemia Market by End User
+ Hospital
+ Clinic
+ Others
Global Acute Myeloid Leukaemia Market by Region
+ North America
+ Latin America
+ Europe
+ Asia Pacific
+ Rest of the World
North America leads the global acute myeloid leukaemia market due to existing patient base and
healthcare setups. Besides, it has unique research and development infrastructure supported by
government funds, leading pharmaceutical enterprises and healthcare organizations. This lead is
further followed by the Europe region which is a hub for medical breakthroughs and skilled
healthcare professionals. The APAC region is estimated to grow at a consistent CAGR in the near
future due to increased awareness about AML, better healthcare infrastructure, rising disposable
income and investment in healthcare innovation.
Purchase a Copy of this Premium Research Report At:
https://www.futurewiseresearch.com/checkout.aspx?ReportId=177&license=single
Competitive Landscape:
+ Tier 1 players- established companies in the market with a major
+ Tier 2 players
+ Emerging players which are growing rapidly
+ New Entrants
market share
FutureWise Key Takeaways
+ Growth prospects
+ SWOT analysis
+ Key trends
+ Key data-points affecting market growth
Objectives of the Study:
+ To provide with an exhaustive analysis on the Global Acute Myeloid Leukaemia Market by Drug
Class, by End User and by Region
+ To cater comprehensive information on factors impacting market growth (drivers, restraints,
opportunities, and industry-specific restraints)
+ To evaluate and forecast micro-markets and the overall market
+ To predict the market size, in key regions (along with countries)—North America, Europe, Asia
Pacific, Latin America, and the Middle East
+ To record evaluate and competitive landscape mapping- product launches, technological
advancements, mergers and expansions
+ Profiling of companies to evaluate their market shares, strategies, financials and core
competencies
Inquire further details about this report at:
[email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility
and customised solutions for our clients. Through in-depth market
insights and consultancy, we present our clients with the tools they need
to be at the forefront of their industry – a position secured for far more
than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Author
Merin John
Merin John263   documents Email
Document
Category
Health and Medicine
Views
4
File Size
16 KB
Tags
healthcare, Medical Business, market, health
1/--pages
Report inappropriate content